Healio Minute

Jan 23 2025 121 ep. 11 mins 5
Healio Minute Podcast artwork

The latest health care news you need, when you need it. Only at Healio.

  Health & Fitness  Science
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Lung Cancer Edition: Top Headlines for Week of January 20, 2025

Jan 23 2025 11 mins  
In this edition, combination extends survival vs. standard first-line therapy, integrated care for smoking cessation during lung cancer screening and more. Read the full coverage here: Combination extends survival vs. standard first-line therapy for advanced lung cancer Integrated care ‘best treatment option’ for smoking cessation during lung cancer screening FDA proposes c

Lung Cancer Edition: Top Headlines for Week of December 16, 2024

Dec 19 2024 13 mins  
In this edition, we bring you Healio’s top lung cancer headlines in 2024. Read the full coverage here: California doctor with lung cancer receives first-of-its-kind lung-liver transplant ‘We were shocked’: Vaping considerably increases lung cancer risk among people who smoke FDA places hold on trial of cell therapy for lung cancer after patient death Findings highlight �

Lung Cancer Edition: Top Headlines for Week of November 11, 2024

Nov 14 2024 10 mins  
In this edition, single-fraction SBRT outcomes for central lung tumors, adjuvant durvalumab extends survival in limited-stage small cell lung cancer and more. Read the full coverage here: Single-fraction SBRT confers ‘surprisingly excellent’ outcomes for central lung tumors Adjuvant durvalumab extends survival in limited-stage small cell lung cancer Depression among people

Lung Cancer Edition: Top Headlines for Week of October 14, 2024

Oct 17 2024 10 mins  
In this edition, FDA approves Rybrevant for advanced lung cancer, screening orders in eligible patients higher with digital health program and more. Read the full coverage here: FDA approves Rybrevant for advanced lung cancer Lung cancer screening orders in eligible patients higher with digital health program FDA approves Opdivo regimen for resectable NSCLC Study quantifies su

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of September 23, 2024

Sep 26 2024 11 mins  
In this edition, blue-collar workers more likely to miss work or quit due to psoriatic arthritis, infliximab biosimilar increase after release of a third option and more. Read the full coverage here: Blue-collar workers more likely to miss work, quit due to psoriatic arthritis Infliximab biosimilar uptake rapidly increased only after release of a third option National Psoriasis

Lung Cancer Edition: Top Headlines for Week of September 16, 2024

Sep 19 2024 13 mins  
In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, ivonescimab ‘may be a new standard’ and more. Read the full coverage here: FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’ Perioperative nivolumab improves outcomes in resectable NSCLC Des

DME/Retina Edition: Top Headlines for Week of September 9, 2024

Sep 12 2024 8 mins  
In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more. Read the full coverage here: Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema OCT, visual acuity popular benchmarks in clinical practice guidelines for DME First patient dosed in phase 2 trial of EC-104 im

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of August 19, 2024

Aug 22 2024 11 mins  
In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more. Read the full coverage here: Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations Opioid use has fallen 15% annually since 2014 in autoimmune rheumatic disease Inhibitor class PsO treatments exhibit similar efficacy in mitigatin

Lung Cancer Edition: Top Headlines for Week of August 12, 2024

Aug 15 2024 15 mins  
In this edition, low education level raises follow-up risk in screening program, screening judgement strongly influenced by clinicians and more. Read the full coverage here: Low education level raises risk for loss to follow-up in lung cancer screening program Lung cancer screening judgement strongly influenced by clinicians Occupational benzene exposure heightens lung cancer l

DME/Retina Edition: Top Headlines for Week of August 5, 2024

Aug 08 2024 11 mins  
In this edition, sozinibercept combination therapy shows durability, comparable improvements with aflibercept and more. Read the full coverage here: Sozinibercept combination therapy shows durability in patients with DME, neovascular AMD VIDEO: Comparable improvements seen with aflibercept 8 mg vs. 2 mg in DME DPP-IV, SGLT2 and GLP-1 drugs do not increase risk for diabetic macu